Tuberculosis drug resistance in Canakkale, Turkey
Central European journal of public health.
2020 Sep ;
28 (3) :
245.
Language English Country Czech Republic Media print
Document type Letter
Persistent link
https://www.medvik.cz/link/pmid32997482
PubMed
32997482
DOI
10.21101/cejph.a5284
Knihovny.cz E-resources
- MeSH
- Antitubercular Agents pharmacology therapeutic use MeSH
- Bacterial Proteins drug effects MeSH
- Ethambutol pharmacology therapeutic use MeSH
- Isoniazid pharmacology therapeutic use MeSH
- Catalase drug effects MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Tuberculosis, Multidrug-Resistant genetics MeSH
- Mycobacterium tuberculosis drug effects isolation & purification MeSH
- Rifampin pharmacology therapeutic use MeSH
- Streptomycin pharmacology therapeutic use MeSH
- Tuberculosis drug therapy epidemiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Geographicals
- Turkey MeSH
- Names of Substances
- Antitubercular Agents MeSH
- Bacterial Proteins MeSH
- Ethambutol MeSH
- Isoniazid MeSH
- Catalase MeSH
- katG protein, Mycobacterium tuberculosis MeSH Browser
- Rifampin MeSH
- Streptomycin MeSH
References provided by Crossref.org
